Macquarie Group Ltd. raised its position in shares of Aetna Inc. (NYSE:AET) by 5.8% during the second quarter, Holdings Channel reports. The institutional investor owned 175,079 shares of the company’s stock after buying an additional 9,547 shares during the period. Macquarie Group Ltd.’s holdings in Aetna were worth $21,382,000 at the end of the most recent quarter.
Other hedge funds have also made changes to their positions in the company. Kentucky Retirement Systems Insurance Trust Fund acquired a new stake in shares of Aetna during the second quarter worth approximately $1,729,000. Kentucky Retirement Systems acquired a new stake in shares of Aetna during the second quarter worth approximately $3,641,000. KAMES CAPITAL plc boosted its stake in shares of Aetna by 1.9% in the second quarter. KAMES CAPITAL plc now owns 654,879 shares of the company’s stock worth $79,980,000 after buying an additional 12,415 shares in the last quarter. Mason Street Advisors LLC acquired a new stake in shares of Aetna during the second quarter worth approximately $5,767,000. Finally, Northwestern Mutual Wealth Management Co. boosted its stake in shares of Aetna by 14.8% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 2,359 shares of the company’s stock worth $289,000 after buying an additional 304 shares in the last quarter. 90.76% of the stock is owned by institutional investors and hedge funds.
Shares of Aetna Inc. (NYSE:AET) traded up 0.19% during midday trading on Friday, hitting $129.57. 1,281,217 shares of the stock traded hands. The stock has a market cap of $45.47 billion, a price-to-earnings ratio of 18.69 and a beta of 0.54. The company’s 50 day moving average price is $114.92 and its 200-day moving average price is $116.41. Aetna Inc. has a 12-month low of $92.42 and a 12-month high of $131.08.
Aetna (NYSE:AET) last issued its quarterly earnings results on Thursday, October 27th. The company reported $2.07 EPS for the quarter, topping the consensus estimate of $2.02 by $0.05. The company earned $15.78 billion during the quarter, compared to analyst estimates of $15.71 billion. Aetna had a net margin of 3.91% and a return on equity of 16.25%. The firm’s revenue was up 5.5% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.90 EPS. On average, equities research analysts expect that Aetna Inc. will post $8.02 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, October 28th. Investors of record on Thursday, October 13th were issued a $0.25 dividend. This represents a $1.00 annualized dividend and a yield of 0.77%. The ex-dividend date was Tuesday, October 11th. Aetna’s payout ratio is presently 14.49%.
AET has been the subject of a number of recent analyst reports. Zacks Investment Research upgraded shares of Aetna from a “sell” rating to a “hold” rating in a research report on Tuesday. Sanford C. Bernstein lowered shares of Aetna from an “outperform” rating to a “market perform” rating and set a $132.00 price target for the company. in a research report on Monday, November 14th. Credit Suisse Group AG upgraded shares of Aetna from a “neutral” rating to an “outperform” rating and upped their price target for the stock from $120.00 to $125.00 in a research report on Friday, November 11th. Barclays PLC reiterated a “buy” rating and issued a $142.00 price target on shares of Aetna in a research report on Monday, November 7th. Finally, Evercore ISI initiated coverage on shares of Aetna in a research report on Thursday, September 22nd. They issued a “buy” rating and a $128.00 price target for the company. Seven analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and an average target price of $132.14.
In related news, Director Jeffrey E. Garten sold 7,100 shares of the business’s stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $116.51, for a total value of $827,221.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 0.90% of the stock is currently owned by corporate insiders.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. The Health Care segment’s products and services consist of medical, pharmacy benefit management services, dental, behavioral health and vision plans offered on both an insured basis and an employer-funded, or administrative services contact, basis and emerging businesses products and services, such as accountable care solutions (ACS).